Tailored smoking cessation for cancer patients shows promise

NCT ID NCT07166120

Recruiting now Symptom relief Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests whether a personalized approach to smoking cessation helps cancer patients quit. Researchers will use patients' clinical, genetic, and biomarker information to create tailored treatment plans. The study involves 112 participants and compares this precision treatment to usual care, measuring quit rates and medication use at 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention with personalized risk feedback and treatment recommendations
What this could lead to: If successful, this could provide a more effective way to help cancer patients quit smoking, potentially improving their survival and quality of life.
What could go wrong: This is a small early-stage feasibility study, so results may not be conclusive. The personalized approach may not work better than standard care, and quitting smoking is difficult even with support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHYSICIAN'S ROLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHYSICIAN'S ROLE SMOKING SMOKING CESSATION

Contacts and locations

Locations

John Cochran Veteran's Affairs Medical Center
RECRUITING

St Louis, Missouri, 63106, United States
Washington University School of Medicine
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.